SOLS Stock Forecast & Price Target

Solstice Advanced Mat is well positioned for durable fundamental growth because its core refrigerants business sits at the intersection of regulatory mandates and secular demand, with HFO mix rising from 27% of stationary refrigerants sales in 2022 to about 60% in 2025 and ~80% expected longer-term. Its niche, mission-critical products in nuclear conversion, electronics, healthcare packaging, and defense benefit from oligopoly structures, long customer tenures, and backlog visibility, while Q2:26 net debt/EBITDA of 1.3x gives substantial flexibility for capex, bolt-on M&A, and the recently announced $500MM buyback. The only US UF6 converter, it also has unique pricing power and supply tightness in a market where pricing has moved from roughly $10/kgU in 2018 to more than $30/kgU currently, supporting margin expansion and mid-SD organic revenue growth.

Solstice Advanced Mat is viewed negatively because its growth engines face multiple policy and demand overhangs: refrigerants depend on a low-GWP transition that could be slowed by weakened EPA enforcement, illegal imports, and redesign costs, while the Nuclear business relies on political support and faces licensing, milestone, and decommissioning risks. Its diversified end markets are still exposed to cyclicality, with weak industrial production and high rates pressuring Building Solutions and Research & Performance Chemicals, and the downside case already assumes weaker EBITDA of $1,093M and an 8.0x EV/EBITDA multiple. Additional drag comes from 43% of 2025 sales being outside the US, 14% exported from the US, plus FX, tariffs, IP infringement in China, raw-material inflation, and legacy environmental liabilities that could exceed reserves.